Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/12527
Title: Oxygen therapy for COPD.
Austin Authors: McDonald, Christine F 
Affiliation: Department of Respiratory and Sleep Medicine, Austin Health, Heidelberg, Victoria, Australia ; 2 Institute for Breathing and Sleep, Melbourne, Victoria, Australia ; 3 University of Melbourne, Melbourne, Victoria, Australia
Issue Date: 1-Nov-2014
Publication information: Journal of Thoracic Disease; 6(11): 1632-9
Abstract: Chronic obstructive pulmonary disease (COPD) is a leading cause of disability and death globally, characterised by progressive breathlessness, loss of function and, in its later stages, chronic hypoxaemia. Long-term continuous oxygen therapy increases life expectancy in patients with severe resting hypoxaemia. However, there are few data to support the use of oxygen in patients with only mild hypoxaemia and more research is required to determine any benefits of oxygen supplementation in COPD in such individuals.
Gov't Doc #: 25478203
URI: http://ahro.austin.org.au/austinjspui/handle/1/12527
DOI: 10.3978/j.issn.2072-1439.2014.10.23
URL: https://pubmed.ncbi.nlm.nih.gov/25478203
Type: Journal Article
Subjects: Oxygen
chronic obstructive pulmonary disease (COPD)
oxygen usage
Appears in Collections:Journal articles

Show full item record

Page view(s)

6
checked on Nov 25, 2022

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.